🔎 Trials Near Me

Utama › Kanser Payudara › California

Kajian klinikal Kanser Payudara di California

179 kajian untuk Kanser Payudara sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of San Diego Moores Cancer Center, La Jolla
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • dan 10 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Onco Inst of Hope and Innovation, Cerritos
  • City of Hope National Medical, Duarte
  • Providence Medical Foundation, Fullerton
  • dan 7 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • dan 20 lagi
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

  • Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
  • Stanford Medicine Cancer Center, Stanford
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07701941

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

  • Oncology Institute, Long Beach
  • Cancer & Blood Research Center, Los Alamitos
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07102381

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California Los Angeles, Los Angeles
  • University of California San Diego Moores Cancer Center, San Diego
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

  • Beverly Hills Cancer Center, Beverly Hills
  • MemorialCare Orange Coast Medical Center, Fountain Valley
  • City of Hope at Orange County Lennar Foundation Cancer Center, Irvine
  • dan 3 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06369285

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

  • City of Hope Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • City of Hope at Long Beach Elm, Long Beach
  • dan 1 lagi
Mengambil pesertaFasa 2
Umur 70 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04305834

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • The Oncology Institute of Hope and Innovation, Cerritos
  • Ellison Medical Institute, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
  • dan 3 lagi
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06324357

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

  • California Protons Cancer Therapy Center, San Diego
Mengambil pesertaFasa 3
Umur 19 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT05856773

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
  • dan 1 lagi
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05877599

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • California Protons Cancer Therapy Center, San Diego
Mengambil pesertaFasa 2
Umur 50 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT01766297

IKS014 in Advanced Solid Tumors That Express HER2

  • Hoag Memorial Hospital Presbyterian, Newport Beach
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05872295

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  • Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles
  • Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07060807

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

  • Los Angeles Cancer Network, Los Angeles
  • Community Clinical Trials, Orange
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT07054190

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Roy and Patricia Disney Family Cancer Center ( Site 0055), Burbank
  • Community Cancer Institute ( Site 0100), Clovis
  • Providence Medical Foundation ( Site 0080), Fullerton
  • dan 4 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06966700

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • Providence Medical Foundation, Eureka
  • Providence Medical Foundation, Santa Rosa
Mengambil pesertaFasa 3
Umur 60 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06377852

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • City of Hope, Duarte
  • UC San Diego Moores Cancer Center, La Jolla
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07007559

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07229313

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

  • Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills
Mengambil pesertaFasa 1
Umur 18 hingga 80 · Wanita · Dikemas kini 23 Sep 2026 · NCT07401381

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

  • Clinical Trial Site, Beverly Hills
  • Clinical Trial Site, La Jolla
  • Clinical Trial Site, Los Alamitos
  • dan 8 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Marin Cancer Care, Greenbrae
  • Loma Linda University, Loma Linda
  • Cancer and Blood Research Center, Los Alamitos
  • dan 3 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Community Cancer Institute, Clovis
  • City of Hope, Duarte
  • Epic Care - Emeryville, Emeryville
  • dan 19 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • City of Hope, Duarte
  • University of California, Los Angeles (UCLA), Santa Monica
  • Stanford University Medical Center, Stanford
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07114601

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • City of Hope, Duarte
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 22 Sep 2026 · NCT07287098

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213791

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  • Disney Family Cancer Center, Burbank
  • City of Hope, Corona
  • City of Hope Comprehensive Cancer Center, Duarte
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05894239

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

  • University of California Irvine, Irvine
  • University of California Los Angeles, Los Angeles
  • University of California Davis, Sacramento
  • dan 2 lagi
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 30 hingga 74 · Wanita · Dikemas kini 21 Sep 2026 · NCT02620852

Pulsed Electric Field Ablation for Metastatic Breast Cancer

  • University of California San Francisco, San Francisco
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07487844

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  • University Of California - San Diego Moores Cancer Center, La Jolla
  • Cancer and Blood Specialty Clinic (CBSC), Los Alamitos
  • Cedar Sinai - Samuel Oschin Cancer Center, Los Angeles
  • dan 4 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • City of Hope, Duarte
  • City of Hope, Irvine, Irvine
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07109726

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

  • Beverly Hills Cancer Center, Beverly Hills
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06827236

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

  • UC Davis, Sacramento
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 94 · Wanita · Dikemas kini 17 Sep 2026 · NCT07505797

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

  • University of California, Los Angeles (Specimen Analysis only), Los Angeles
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06780176

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • UCSF Cancer Center Berkeley, Berkeley
  • Cedars-Sinai Cancer Beverly Hills, Beverly Hills
  • City of Hope National Medical Center, Duarte
  • dan 19 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06492616

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.